|
Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTE™
RECRUITINGSponsored by Proteocyte Diagnostics Inc.
Actively Recruiting
SponsorProteocyte Diagnostics Inc.
Started2023-01-01
Est. completion2024-12
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations5 sites
View on ClinicalTrials.gov →
NCT05853783
Summary
The purpose of this study is to validate the ability of the STRATICYTE™ predictive model to predict the transformation of oral potentially malignant disorders (OPMDs) to oral squamous cell carcinoma (OSCC) in a retrospective cohort of patients who received biopsies.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * From the archive, any patient who presents with clinically evident oral lesions and biopsy-proven dysplasia (punch or scalpel biopsies; any grade or classification system) * Patients with initial oral lesions with epithelial atypia suspicious for neoplasia, with: * No histological evidence of cancer with clinical follow-up data for a period of at least five years; or * OSCC development (histologic or documented evidence of invasive cancer). * Patients who had archived biopsy tissue blocks of a previous oral lesion(s) meeting the above criteria and retained at the same clinical center. Exclusion Criteria: * Patients with oral lesions or dysplasia with no indication of OSCC development or follow-up data of less than five years in non-OSCC patients. * Patients diagnosed with oral epithelial dysplasia concomitant with OSCC at the time of the biopsy's original pathology report or a subsequent clinical note of cancer progression within three months post-biopsy.
Conditions2
CancerMouth Diseases
Locations5 sites
Alabama
1 siteThe University of Alabama at Birmingham
Birmingham, Alabama, 35233
California
1 siteLoma Linda University
Loma Linda, California, 92350
Minnesota
1 siteMinnesota Oral and Facial Surgery
Minneapolis, Minnesota, 55415
Texas
2 sitesMD Anderson Cancer Cetner
Houston, Texas, 44907
Andrew G Sikora, MD, PhD
UTHealth Houston School of Dentistry
Houston, Texas, 77054
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorProteocyte Diagnostics Inc.
Started2023-01-01
Est. completion2024-12
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations5 sites
View on ClinicalTrials.gov →
NCT05853783